Total Valuation
Onco-Innovations Ltd. has a market cap or net worth of C$101.76M. The enterprise value is C$88.25M.
Market CapC$101.76M
Enterprise ValueC$88.25M
Share Statistics
Onco-Innovations Ltd. has 69,224,365 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding69,224,365
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Onco-Innovations Ltd.’s return on equity (ROE) is -1.16 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)-1.16
Return on Assets (ROA)-0.76
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee0.00
Profits Per Employee-64.37K
Employee Count1
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Onco-Innovations Ltd. is ―. Onco-Innovations Ltd.’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Onco-Innovations Ltd. had revenue of 0.00 and earned -420.65K in profits. Earnings per share was -0.01.
Revenue0.00
Gross Profit0.00
Operating Income0.00
Pretax Income-420.65K
Net Income-420.65K
EBITDA-265.63K
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -2.68M and capital expenditures 0.00, giving a free cash flow of -2.68M billion.
Operating Cash Flow-2.68M
Free Cash Flow-2.68M
Free Cash Flow per Share-0.04
Dividends & Yields
Onco-Innovations Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.63
52-Week Price Change0.00%
50-Day Moving Average1.47
200-Day Moving Average1.47
Relative Strength Index (RSI)―
Average Volume (3m)51.23K
Important Dates
Onco-Innovations Ltd. upcoming earnings date is Dec 23, 2026, During Market Hours (Confirmed).
Last Earnings DateSep 14, 2026
Next Earnings DateDec 23, 2026
Ex-Dividend Date―
Financial Position
Onco-Innovations Ltd. as a current ratio of 2.62, with Debt / Equity ratio of 0.00%
Current Ratio2.62
Quick Ratio2.62
Debt to Market Cap0.00
Net Debt to EBITDA1.88
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Onco-Innovations Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Onco-Innovations Ltd. EV to EBITDA ratio is 1.88, with an EV/FCF ratio of 79.36.
EV to Sales0.00
EV to EBITDA1.88
EV to Free Cash Flow79.36
EV to Operating Cash Flow79.36
Balance Sheet
Onco-Innovations Ltd. has C$1.41M in cash and marketable securities with C$0.00 in debt, giving a net cash position of C$1.41M billion.
Cash & Marketable SecuritiesC$1.41M
Total DebtC$0.00
Net CashC$1.41M
Net Cash Per ShareC$0.02
Tangible Book Value Per ShareC$0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Onco-Innovations Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast7.18%
EPS Growth Forecast24.44%